Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

GERN
Geron Corp
stock NASDAQ

At Close
Jul 1, 2026 3:59:56 PM EDT
1.27USD-0.781%(-0.01)9,906,530
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jul 1, 2026 9:27:30 AM EDT
1.28USD0.000%(0.00)12,100
After-hours
Jul 1, 2026 4:39:30 PM EDT
1.27USD0.000%(0.00)913,293
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 21, 2022
07:30AM EST  Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference   Business Wire
Jan 20, 2022
04:30PM EST  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Jan 4, 2022
05:01PM EST  Geron to Present at the H.C. Wainwright BioConnect Conference   Business Wire
Dec 16, 2021
04:30PM EST  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Dec 14, 2021
04:30PM EST  Geron Reports Presentations at American Society of Hematology Annual Meeting   Business Wire
Dec 2, 2021
07:33AM EST  Geron Appoints Edward Koval As EVP And Chief Business Officer   RTTNews
07:30AM EST  Geron Announces Appointment of Chief Business Officer   Business Wire
Nov 18, 2021
04:30PM EST  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Nov 12, 2021
07:30AM EST  Geron to Present at the Stifel 2021 Virtual Healthcare Conference   Business Wire
Nov 9, 2021
06:00PM EST  Geron Presents Investor Event Highlights   Business Wire
Nov 4, 2021
09:12AM EDT  Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting   Business Wire
Nov 2, 2021
11:11AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021   Benzinga
10:42AM EDT  Baird Initiates Coverage On Geron with Outperform Rating, Announces Price Target of $4   Benzinga
Oct 25, 2021
04:33PM EDT  Geron Says Enters Into New Innovative Licensing And Access Pathway In U.K. For Imetelstat   Benzinga
04:30PM EDT  Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat   Business Wire
Oct 21, 2021
04:30PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Oct 18, 2021
07:36AM EDT  Geron Completes Patient Enrollment In IMerge Phase 3 Trial In Lower Risk Myelodysplastic Syndromes   RTTNews
07:32AM EDT  Geron Announces Completion Of Patient Enrollment In IMerge Phase 3 Clinical Trial In Lower Risk Myelodysplastic Syndromes   Benzinga
Oct 15, 2021
04:05PM EDT  Geron to Host a Virtual Investor Event in November   Business Wire
Oct 12, 2021
08:13AM EDT  The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology   Benzinga
05:47AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.30 A.M. EDT).   RTTNews
Oct 11, 2021
04:44PM EDT  Geron Highlights Publication Of Analyses Comparing Real World Data To IMbark Phase 2 In 'Annals Of Hematology'   Benzinga
04:30PM EDT  Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology   Business Wire
Oct 4, 2021
12:06PM EDT  Geron Earnings Perspective: Return On Capital Employed   Benzinga
Sep 16, 2021
04:30PM EDT  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Sep 1, 2021
04:30PM EDT  Geron Announces September Investor Conference Presentation Webcasts   Business Wire
Aug 19, 2021
04:30PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 16, 2021
04:45PM EDT  Recap: Geron Q2 Earnings   Benzinga
04:09PM EDT  Geron Q2 EPS $(0.09) Misses $(0.08) Estimate, Sales $107.00K Beat $60.00K Estimate   Benzinga
04:06PM EDT  Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023   Business Wire
04:04AM EDT  Earnings Scheduled For August 16, 2021   Benzinga
Aug 10, 2021
02:42PM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Aug 5, 2021
04:30PM EDT  Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021   Business Wire
Jul 22, 2021
04:45PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Jun 24, 2021
09:49AM EDT  Return On Capital Employed Overview: Geron   Benzinga
Jun 18, 2021
03:05PM EDT  Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; CAI International Shares Spike Higher   Benzinga
12:18PM EDT  Mid-Day Market Update: Crude Oil Rises Over 1%; Orphazyme Shares Plunge   Benzinga
07:46AM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Jun 17, 2021
04:30PM EDT  Geron Announces Publication Of IMbark Phase 2 Data In Journal Of Clinical Oncology   Benzinga
Jun 14, 2021
04:30PM EDT  Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress   Business Wire
Jun 8, 2021
11:35AM EDT  Geron: Return On Capital Employed Insights   Benzinga
May 12, 2021
11:06AM EDT  Geron Announces Two Presentations At Upcoming European Hematology Association Annual Congress   RTTNews
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 10, 2021
04:47PM EDT  Geron: Q1 Earnings Insights   Benzinga
04:46PM EDT  Geron Q1 EPS $(0.09) Misses $(0.08) Estimate, Sales $137.00K Beat $50.00K Estimate   Benzinga
04:11PM EDT  Geron Q1 Loss/Shr $0.09 Vs Loss $0.08 Last Year   RTTNews
04:06PM EDT  Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights   Business Wire
04:09AM EDT  Earnings Scheduled For May 10, 2021   Benzinga
May 3, 2021
04:30PM EDT  Geron to Announce First Quarter 2021 Financial Results on May 10, 2021   Business Wire
Apr 22, 2021
04:30PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Apr 13, 2021
07:46AM EDT  Biopharmaceutical company Geron Corp. (GERN) announced Tuesday that the first patient has been dosed in IMpactMF, the Phase 3 clinical trial evaluating imetelstat, a first-in-class telomerase inhibitor, in refractory myelofibrosis (MF).   RTTNews
07:35AM EDT  Geron Says First Patient Has Been Dosed In IMpactMF Phase 3 Clinical Trial In Refractory Myelofibrosis   RTTNews
07:31AM EDT  Geron Announces First Patient Dosed In IMpactMF Phase 3 Clinical Trial In Refractory Myelofibrosis   Benzinga
Mar 18, 2021
04:45PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Mar 12, 2021
07:36AM EST  The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs   Benzinga
Mar 11, 2021
04:21PM EST  Geron Corp. Q4 Loss/share $0.07 Vs. Loss $0.15 Year Ago   RTTNews
04:14PM EST  Geron Q4 EPS $(0.07) Misses $(0.06) Estimate, Sales $50.00K Inline   Benzinga
04:10PM EST  Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights   Business Wire
08:19AM EST  The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena   Benzinga
03:35AM EST  Earnings Scheduled For March 11, 2021   Benzinga
Mar 10, 2021
10:08AM EST  Geron's Earnings Outlook   Benzinga
Mar 6, 2021
10:58AM EST  The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings   Benzinga
Mar 1, 2021
04:45PM EST  Geron to Announce Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021   Business Wire
Feb 18, 2021
04:45PM EST  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Jan 14, 2021
04:45PM EST  Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference   Business Wire
Dec 11, 2020
08:35AM EST  Geron Plans For IMpactMF To Evaluate Imetelstat Compared To Best Available Therapy In 320 Patients   RTTNews
08:31AM EST  Geron Announces Opening Of IMpactMF Phase 3 Clinical Trial In Refractory Myelofibrosis   Benzinga
Dec 10, 2020
08:36AM EST  Geron Announces 50% Enrollment Milestone In IMerge Phase 3 Clinical Trial In Lower Risk MDS   Benzinga
08:34AM EST  Geron Reports Achievement Of 50% Enrollment In IMerge Phase 3 Clinical Trial Of Imetelstat In Lower Risk MDS   RTTNews
08:30AM EST  Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS   Business Wire
Dec 7, 2020
07:40PM EST  Geron Says Imetelstat Presentations Provide Strong Support For two Registration-enabling Phase 3 Trials   RTTNews
06:45PM EST  Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting   Business Wire
Nov 19, 2020
04:30PM EST  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Nov 10, 2020
04:30PM EST  Geron to Present at the Stifel Virtual Healthcare Conference   Business Wire
Nov 5, 2020
05:08PM EST  Geron Q3 EPS $(0.06), Inline, Sales $108.00K Beat $40.00K Estimate   Benzinga
04:25PM EST  Recap: Geron Q3 Earnings   Benzinga
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 4, 2020
04:27PM EST  Geron Announces Ten Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting   Business Wire
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 29, 2020
04:30PM EDT  Geron to Announce Third Quarter Financial Results on November 5, 2020   Business Wire
Oct 28, 2020
05:03PM EDT  Geron Announces Publication Of IMerge Phase 2 Data In Journal Of Clinical Oncology   Benzinga
Oct 1, 2020
04:30PM EDT  Geron Reports Secured $75M Loan Facility With Hercules Capital   Benzinga
04:30PM EDT  Geron Secures Loan Facility for Up to $75 Million   Business Wire
Sep 17, 2020
04:30PM EDT  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Sep 9, 2020
09:00AM EDT  Geron to Present at the H.C. Wainwright Global Investment Conference   Business Wire
Aug 26, 2020
08:14AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
06:04AM EDT  HC Wainwright & Co. Maintains Buy on Geron, Raises Price Target to $7   Benzinga
Aug 20, 2020
04:30PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Aug 6, 2020
05:20PM EDT  Geron Q2 EPS $(0.06), Inline, Sales $43.00K Miss $60.00K Estimate   Benzinga
04:28PM EDT  Geron Q2 Loss/Shr $0.06 Vs Loss $$0.08 Last Year   RTTNews
04:06PM EDT  Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events   Business Wire
Aug 4, 2020
04:45PM EDT  Geron to Present at the BTIG Virtual Biotechnology Conference   Business Wire
Aug 3, 2020
09:32AM EDT  Benzinga's Top Upgrades, Downgrades For August 3, 2020   Benzinga
07:42AM EDT  Stifel Initiates Coverage On Geron with Buy Rating   Benzinga
Jul 30, 2020
04:30PM EDT  Geron to Announce Second Quarter Financial Results on August 6, 2020   Business Wire
Jul 16, 2020
08:36AM EDT  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC